Bharat Biotech vaccine may come in the first quarter of next year.
Covid-19 Vaccine Update: Bharat Biotech vaccine may come in the first quarter of next year. The company’s joint managing director Suchitra Ela said on Wednesday that she expects Covaxin to be available in the first quarter of next year with data on safety and capacity. He said that this vaccine is expected to be given to the first category in the first quarter of 2021 as per the Government of India’s phased vaccination plan. On Wednesday, the Ministry of External Affairs organized a tour of the heads of the mission and their representatives.
Information about manufacturing capacity given to ambassadors
The group also went to the research and manufacturing facilities of Bharat Biotech and Biological E. The ministry said that they were informed about efforts to develop India’s indigenous COVID-19 vaccine, which includes ongoing clinical trials. In India’s pharmaceutical sector, including the production of vaccines, R&D facilities, manufacturing capacity, foreign agreements, etc. were mentioned.
Dr. Krishna Ila, Chairman and Managing Director of Bharat Biotech, gave an update on the project regarding the vaccine. At the presentation, the ambassadors were told that 33 percent of the world’s vaccine is produced in Hyderabad’s Genome Valley. Suchitra Ila, Joint Managing Director of Bharat Biotech, said that the development and clinical evaluation of Covaxin is an important step in the field of novel vaccination in India.
Covid-19 Vaccine: Price Of Pfizer Vaccine Will Be Different For Different Countries, Lower Price For Low Income Countries
He said that many countries around the world have shown interest in supplying and presenting Covaxin. It is an honor to have the distinguished ambassadors of many countries present. He said that it not only makes Gajnav, but also reminds that the world is looking towards India in the fight against this pandemic.